Becton, Dickinson and Company (LON:0R19)

Market Cap	43.04B
Revenue (ttm)	16.49B
Net Income (ttm)	1.38B
Shares Out	n/a
EPS (ttm)	4.75
PE Ratio	31.20
Forward PE	n/a
Dividend	3.09 (1.54%)
Ex-Dividend Date	Mar 10, 2025

Volume	64
Average Volume	406
Open	199.50
Previous Close	200.67
Day's Range	198.71 - 200.74
52-Week Range	202.47 - 286.33
Beta	0.38
RSI	28.94
Earnings Date	May 1, 2025

About LON:0R19

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1897
• Employees: 74,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0R19

Financial Performance

In 2024, LON:0R19's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.

Financial numbers in USD